These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2663140)

  • 21. Nuclear magnetic resonance analysis of tumor necrosis factor-induced alterations of phospholipid metabolites and pH in Friend leukemia cell tumors and fibrosarcomas in mice.
    Podo F; Carpinelli G; Di Vito M; Giannini M; Proietti E; Fiers W; Gresser I; Belardelli F
    Cancer Res; 1987 Dec; 47(24 Pt 1):6481-9. PubMed ID: 3677088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow.
    Koutcher JA; Motwani M; Zakian KL; Li XK; Matei C; Dyke JP; Ballon D; Yoo HH; Schwartz GK
    Clin Cancer Res; 2000 Apr; 6(4):1498-507. PubMed ID: 10778982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of magnetic resonance imaging in the tissue characterization of tumors].
    Biagini C
    Radiol Med; 1986 Jun; 72(6):379-92. PubMed ID: 3520712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of nuclear magnetic resonance spectroscopy (MRS) in cancer diagnosis and treatment: 31P, 23Na, and 1H MRS studies of three models of pancreatic cancer.
    Kaplan O; Kushnir T; Askenazy N; Knubovets T; Navon G
    Cancer Res; 1997 Apr; 57(8):1452-9. PubMed ID: 9108445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiation dose-dependent changes in tumor metabolism measured by 31P nuclear magnetic resonance spectroscopy.
    Mahmood U; Alfieri AA; Thaler H; Cowburn D; Koutcher JA
    Cancer Res; 1994 Sep; 54(18):4885-91. PubMed ID: 8069854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease.
    Gonzalez RG; Guimaraes AR; Moore GJ; Crawley A; Cupples LA; Growdon JH
    Alzheimer Dis Assoc Disord; 1996; 10(1):46-52. PubMed ID: 8919496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging of tumors of the central nervous system.
    Scotti G; Falini A
    Curr Opin Radiol; 1992 Feb; 4(1):52-62. PubMed ID: 1739602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Application of multinuclear in vivo magnetic resonance spectroscopy in oncology].
    Semmler W; Gückel F; Bachert-Baumann P; Lorenz WJ; van Kaick G
    Radiologe; 1989 Jul; 29(7):330-5. PubMed ID: 2667032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and P MRS applications.
    Khan SA; Cox IJ; Hamilton G; Thomas HC; Taylor-Robinson SD
    Liver Int; 2005 Apr; 25(2):273-81. PubMed ID: 15780050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring human tumor response to therapy by means of P-31 MR spectroscopy.
    Semmler W; Gademann G; Bachert-Baumann P; Zabel HJ; Lorenz WJ; van Kaick G
    Radiology; 1988 Feb; 166(2):533-9. PubMed ID: 3336731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo MR spectroscopic imaging with P-31. Work in progress.
    Maudsley AA; Hilal SK; Simon HE; Wittekoek S
    Radiology; 1984 Dec; 153(3):745-50. PubMed ID: 6494470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of MR spectroscopy to the study of tumor biology.
    Boddie AW; Frazer JW; Tomasovic SP; Dennis L
    J Surg Res; 1989 Jan; 46(1):90-7. PubMed ID: 2644490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phospholipid metabolites as indicators of cancer cell function.
    Ruiz-Cabello J; Cohen JS
    NMR Biomed; 1992; 5(5):226-33. PubMed ID: 1449961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of in vivo NMR spectroscopy to cancer.
    Evanochko WT; Ng TC; Glickson JD
    Magn Reson Med; 1984 Dec; 1(4):508-34. PubMed ID: 6400586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calculated T1 and T2 MR images and 31P MR spectra in rabbit thigh V2 carcinoma to monitor the effect of steroid administration.
    Marincek B; Friedburg H
    Invest Radiol; 1985 Oct; 20(7):701-7. PubMed ID: 4066241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphodiesters in saponified extracts of human breast and colon tumors using 31P magnetic resonance spectroscopy.
    Merchant TE; Characiejus D; Kasimos JN; Den Otter W; Gierke LW; Glonek T
    Magn Reson Med; 1992 Jul; 26(1):132-40. PubMed ID: 1320725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic changes underlying 31P MR spectral alterations in human hepatic tumours.
    Bell JD; Bhakoo KK
    NMR Biomed; 1998 Nov; 11(7):354-9. PubMed ID: 9859941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions.
    Glunde K; Ackerstaff E; Mori N; Jacobs MA; Bhujwalla ZM
    Mol Pharm; 2006; 3(5):496-506. PubMed ID: 17009848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proceedings of a National Cancer Institute workshop: MR spectroscopy and tumor cell biology.
    Negendank WG; Brown TR; Evelhoch JL; Griffiths JR; Liotta LA; Margulis AR; Morrisett JD; Ross BD; Shtern F
    Radiology; 1992 Dec; 185(3):875-83. PubMed ID: 1438779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphorus MR spectroscopy in the treatment of human extremity sarcomas.
    Sijens PE
    NMR Biomed; 1998 Nov; 11(7):341-53. PubMed ID: 9859940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.